SSA
DVAX

Sierra Summit Advisors’s Dynavax Technologies DVAX Stock Holding History

Sierra Summit Advisors’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-35,038
Closed -$490K – 166
2023
Q4 		$490K Buy
+35,038
New +$487K 0.14% 86

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sierra Summit Advisors's DVAX Position: Q1 2024 in Review

Sierra Summit Advisors sold out of Dynavax Technologies (DVAX) in Q1 2024, closing a stake of 35,038 shares — an estimated $490K sold.

Sierra Summit Advisors first reported a position in DVAX in Q4 2023 and held it in 1 quarter. The position peaked at $490K in Q4 2023. 244 funds tracked by Wall St. Rank hold DVAX as of Q1 2024.

  • Sierra Summit Advisors reported no remaining Dynavax Technologies position as of Q1 2024 after selling out during the quarter.
  • Sierra Summit Advisors sold 35,038 Dynavax Technologies shares in Q1 2024, an estimated $490K.
  • Sierra Summit Advisors first reported a position in Dynavax Technologies in Q4 2023 and held it in 1 quarter.
  • Sierra Summit Advisors's Dynavax Technologies position peaked at $490K in Q4 2023.
  • 244 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2024.

Based on Sierra Summit Advisors's 13F filing for Q1 2024, filed 9 May 2024.